Hypoglycemic News and Research

RSS

Novel method for glucagon delivery to help individuals living with Type 1 diabetes

For children with Type 1 diabetes, the risk of experiencing a severe hypoglycemic episode is especially common -- and for parents, the threat of that happening in the middle of the night is especially frightening.

20 Jul 2021

Study may provide a basis for oral insulin development using DNP peptides

Researchers from Kumamoto University, Japan have found that DNP peptide, a small intestine-permeable cyclic peptide originally used as an insulin additive to improve absorption into the small intestinal, lowers blood glucose levels in mice.

26 Apr 2021

Anti-diabetic drug phenformin may prompt stronger cancer-fighting activities

The anti-diabetic drug phenformin may prompt stronger cancer-fighting activities than its sister compound metformin, a finding that could have major implications for current and future clinical trials investigating both agents for their anti-cancer potential, according to researchers at Massachusetts General Hospital (MGH).

15 Apr 2021

Can metformin reduce mortality in diabetic individuals with severe COVID-19?

A new study by researchers in China and the U.S. describes a round-up of the effects of commonly used hypoglycemic drugs on the outcomes of COVID-19 in diabetic patients.

1 Feb 2021

Novel, highly specific treatment method for hyperinsulinemic hypoglycemia

A new method to treat hyperinsulinemic hypoglycemia has proven highly selective in targeting lesions and effective in slowing tumor growth, according to research published in the November issue of the Journal of Nuclear Medicine.

9 Nov 2020

FDA approves a hybrid closed loop diabetes management device for young pediatric patients

Today, the U.S. Food and Drug Administration approved the MiniMed 770G System, a hybrid closed loop diabetes management device that is intended to automatically monitor glucose (sugar) and provide appropriate basal insulin doses with little or no input from the users or their caregivers for use by individuals aged 2 to 6 with type 1 diabetes.

31 Aug 2020

Novel drug candidate offers a major advance in the treatment for diabetes

The University of Alabama at Birmingham and Southern Research have discovered a new drug candidate that offers a major advance in the treatment for diabetes.

28 Jul 2020

Study claims eating vegetables lower COVID-19 death rates

A preliminary study by researchers in Europe claims that coronavirus disease 2019 (COVID-19) mortality rates may be lower in countries where people consume high amounts of cabbage and cucumber.

20 Jul 2020

Use of continuous glucose monitoring reduces hypoglycemia in seniors with T1D

Results from a six-month, multi-site clinical trial called the Wireless Innovation for Seniors with Diabetes Mellitus Study Group have been published by the Journal of the American Medical Association.

16 Jun 2020

Anosmia and changes in brain MRI in COVID-19

Even as the COVID-19 pandemic was sweeping across the world, new symptoms and clinical presentations appeared, often confusing the picture. A case report from Italy, published in the journal JAMA Neurology in May 2020, shows that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may be a neurotropic virus, and may cause infection to present primarily with anosmia.

31 May 2020

Study: Unique glucose-sensing neurons in the brain prevent severe hypoglycemia

Low blood sugar levels, known as hypoglycemia, can be a life-threatening situation, especially for people with type 1 diabetes who rely on intensive insulin therapy to prevent blood sugar from going too high.

4 May 2020

Diabetes over-treatment could be more dangerous for elderly find study

Diabetes, especially type 2 diabetes mellitus affects a large population across the globe. Treatment usually comprises of the use of oral drugs that could reduce the blood sugar and keep the glycosylated hemoglobin levels or HbA1c less than 7 percent.

19 Feb 2020

AI replaces prick test to detect blood sugar levels

Tracking fluctuations in blood glucose levels is crucial for monitoring diabetic patients. Strict glucose monitoring reduces the risk of hypoglycemia, which can be potentially fatal if it’s not treated promptly.

14 Jan 2020

First-ever quality measures focus on treatment for older adults with hypoglycemia risk

The Endocrine Society and Avalere Health introduced the first-ever quality measures to help healthcare providers assess how well they identify and care for older adults at greater risk of hypoglycemia--low blood sugar that can be a dangerous complication of diabetes treatment.

12 Dec 2019

Some plant foods causing paralysis, death, in malnourished populations

There are a lot of plants eaten for food that may also contain toxins that harm the brain and the nervous system, when present in amounts that cross the limit of individual tolerance. This happens when such toxin-containing foods are the chief or only source of nutrition.

26 Oct 2019

Could drinking a small amount of alcohol everyday be good for type 2 diabetes?

A new meta-analysis suggests that people with type 2 diabetes may benefit from light-to-moderate drinking, which could have a positive effect on blood glucose and fat metabolism.

18 Sep 2019

Prestigious grant to use AI for better glucose control

The ARTORG Center for Biomedical Engineering Research of the University of Bern is the recipient of a grant from JDRF, the leading global funder for type 1 diabetes research.

17 Sep 2019

How much control is too much in type 1 diabetes?

Type 1 diabetes mellitus (T1DM) affects thousands of children, and causes high sugar levels because of low insulin production. In places with good access to medical care, blood glucose is first measured by capillary blood testing or continuous monitoring. Insulin is given as required by subcutaneous injection or insulin pump.

29 Aug 2019

Nurse-directed initiative results in sustained reduction of hypoglycemia

A nurse-directed initiative to examine the root causes of hypoglycemic episodes resulted in a sustained reduction in hypoglycemia among critically ill patients at Stamford Hospital in Connecticut, according to a study published in the August issue of Critical Care Nurse.

2 Aug 2019

FDA approves first nasal glucagon therapy for treatment of severe hypoglycemia

The U.S. Food and Drug Administration today approved Baqsimi nasal powder, the first glucagon therapy approved for the emergency treatment of severe hypoglycemia that can be administered without an injection.

24 Jul 2019